2026-03-18 12:53:10
SRx Health Solutions, Inc. Secures $8 Million Through Private Placement of Series B Preferred Stock
Expected Stock impact: Slightly Positive
On March 16, 2026, SRx Health Solutions, Inc., a Delaware corporation, announced the completion of a Securities Purchase Agreement with accredited investors, allowing the company to raise up to $8 million through the sale of Series B convertible preferred stock and accompanying warrants. The initial closing resulted in the issuance of 5,660 shares of Series B Preferred Stock and 22,237,666 warrants to purchase common stock, generating approximately $4.528 million in cash proceeds. The Series B Preferred Stock has a par value of $0.001 per share and is designed to enhance the company's capital structure while providing investors with conversion rights into common stock at a fixed price of $0.3182. The warrants associated with this offering will expire three years from their initial exercisability date and are subject to adjustments based on market conditions. This financing is expected to strengthen SRx Health Solutions' liquidity position, enabling the company to pursue its strategic initiatives and operational goals effectively. The company is required to seek stockholder approval for the issuance of common stock upon conversion of the Series B Preferred Stock and exercise of the warrants, ensuring compliance with NYSE American regulations. The successful completion of this private placement reflects investor confidence in SRx Health Solutions' growth potential and operational execution, positioning the company for future success.
